Isosorbid Dinitrat Arena (Isosorbide Dinitrate)

The drug releases nitric oxide after oral absorption. Nitric oxide activates soluble guanylate cyclase, increasing cyclic GMP levels in vascular smooth muscle. Elevated cGMP causes smooth‑muscle relaxation, leading to venous and arterial dilation, lower preload and afterload, and reduced myocardial oxygen consumption.

The specific dose is determined by the prescribing clinician based on the individual’s clinical condition, response, and tolerance. Physicians typically start with a low dose and titrate upward as needed, following established guidelines for angina or heart‑failure management.

Safety data for isosorbide dinitrate in pregnancy and lactation are limited. It should only be used when the potential benefit justifies any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Compared with beta‑blockers or calcium‑channel blockers, isosorbide dinitrate provides rapid vasodilation and is particularly effective for acute relief of chest pain. Unlike long‑acting nitrates, it may require multiple daily dosing and has a higher incidence of headache, but it offers a valuable option when other agents are contraindicated or insufficient.

Store at room temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

The medication is taken orally, usually with a full glass of water. It can be taken with or without food, but patients should follow the prescribing clinician’s instructions regarding timing relative to meals to minimize gastrointestinal discomfort.

The most critical adverse events include severe hypotension, which can lead to syncope or shock, and rare cases of myocardial infarction triggered by abrupt blood‑pressure changes. Patients should seek immediate medical attention if they experience sudden dizziness, fainting, or chest pain.

Contraindications include patients with known hypersensitivity to isosorbide dinitrate or other organic nitrates, those with severe hypotension, recent myocardial infarction, or uncontrolled heart failure. Caution is also advised for individuals using phosphodiesterase‑5 inhibitors, as the combination can cause dangerous blood‑pressure drops.